Similar articles

• Impact of shorter-acting neuromuscular blocking agents on fast-track recovery of the cardiac surgical patient.

  Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS, Rosengart TK. Murphy GS, et al. Anesthesiology. 2002 Mar;96(3):600-6. doi: 10.1097/00000542-200203000-00015. Anesthesiology. 2002. PMID: 11873034 Clinical Trial.
• Pancuronium added to intravenous regional anesthesia: systemic weakness after prolonged tourniquet inflation time.

  Sarkiss MG, Daley MD, Norman PH, Coveler LA. Sarkiss MG, et al. Can J Anaesth. 2001 Jan;48(1):102. doi: 10.1007/BF03019827. Can J Anaesth. 2001. PMID: 11212041 No abstract available.
• Residual neuromuscular block caused by pancuronium after cardiac surgery.

  Van Oldenbeek C, Knowles P, Harper NJ. Van Oldenbeek C, et al. Br J Anaesth. 1999 Aug;83(2):338-9. doi: 10.1093/bja/83.2.338. Br J Anaesth. 1999. PMID: 10618955
• Pancuronium bromide: a review of its pharmacological properties and clinical application.

  Speight TM, Avery GS. Speight TM, et al. Drugs. 1972;4(3):163-226. doi: 10.2165/00003495-197204030-00002. Drugs. 1972. PMID: 4264763 Review. No abstract available.
• Pancuronium bromide.

  Roizen MF, Feeley TW. Roizen MF, et al. Ann Intern Med. 1978 Jan;88(1):64-8. doi: 10.7326/0003-4819-88-1-64. Ann Intern Med. 1978. PMID: 339801 Review.